Literature DB >> 29300100

Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.

Kate Wolitzky-Taylor1, Jennifer Krull2, Richard Rawson1, Peter Roy-Byrne3, Richard Ries3, Michelle G Craske2.   

Abstract

OBJECTIVE: Anxiety and substance use disorders are highly comorbid and mutually maintain each other. Treatments for anxiety disorders that are well integrated into substance use disorder treatment have the potential to improve both anxiety and substance use outcomes.
METHOD: Ninety-seven individuals seeking treatment at a community-based, evidence-based intensive outpatient program for substance use disorders who also had anxiety disorders were randomized to either (a) usual care (UC) at the intensive outpatient program; or (b) UC + coordinated anxiety learning and management for addiction recovery centers (CALM ARC), a 7-session, group-based, computer-assisted but therapist-directed treatment for anxiety disorders adapted for individuals with anxiety disorder and substance use disorder comorbidity.
RESULTS: CALM ARC + UC outperformed UC on measures of anxiety and substance use at posttreatment and at a 6-month follow-up.
CONCLUSIONS: Adding CALM ARC to UC for patients with comorbid anxiety disorders and substance use disorders is superior to UC alone. Implications for future research and clinical practice are discussed. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Year:  2018        PMID: 29300100      PMCID: PMC5757285          DOI: 10.1037/ccp0000276

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  23 in total

Review 1.  Treatment for anxiety disorders: Efficacy to effectiveness to implementation.

Authors:  Michelle G Craske; Peter P Roy-Byrne; Murray B Stein; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky
Journal:  Behav Res Ther       Date:  2009-07-14

2.  Direct-to-consumer marketing of evidence-based psychological interventions: introduction.

Authors:  Lauren C Santucci; R Kathryn McHugh; David H Barlow
Journal:  Behav Ther       Date:  2011-07-28

3.  Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.

Authors:  Peter Roy-Byrne; Michelle G Craske; Greer Sullivan; Raphael D Rose; Mark J Edlund; Ariel J Lang; Alexander Bystritsky; Stacy Shaw Welch; Denise A Chavira; Daniela Golinelli; Laura Campbell-Sills; Cathy D Sherbourne; Murray B Stein
Journal:  JAMA       Date:  2010-05-19       Impact factor: 56.272

4.  Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients.

Authors:  Matt G Kushner; Kenneth Abrams; Paul Thuras; Karen L Hanson; Marjorie Brekke; Sandra Sletten
Journal:  Alcohol Clin Exp Res       Date:  2005-08       Impact factor: 3.455

5.  The impact of comorbid anxiety and depression on alcohol treatment outcomes.

Authors:  Lucy Burns; Maree Teesson; Katy O'Neill
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

6.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

7.  Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Wilson M Compton; Yonette F Thomas; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-05

8.  Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).

Authors:  Laura Campbell-Sills; Sonya B Norman; Michelle G Craske; Greer Sullivan; Ariel J Lang; Denise A Chavira; Alexander Bystritsky; Cathy Sherbourne; Peter Roy-Byrne; Murray B Stein
Journal:  J Affect Disord       Date:  2008-05-16       Impact factor: 4.839

Review 9.  Posttraumatic stress disorder and substance abuse. Clinical issues.

Authors:  E P Nace
Journal:  Recent Dev Alcohol       Date:  1988

10.  Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment.

Authors:  Joshua P Smith; Sarah W Book
Journal:  Addict Behav       Date:  2009-08-07       Impact factor: 3.913

View more
  4 in total

1.  The Role of Affect in Psychosocial Treatments for Substance Use Disorders.

Authors:  Julia E Swan; Victoria R Votaw; Elena R Stein; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-06-01

Review 2.  Integrating Treatment for Co-Occurring Mental Health Conditions.

Authors:  Amy M Yule; John F Kelly
Journal:  Alcohol Res       Date:  2019-01-01

3.  Amplification of Positivity Therapy for Co-occurring Alcohol Use Disorder with Depression and Anxiety Symptoms: Pilot Feasibility Study and Case Series.

Authors:  Elisabeth Akeman; Evan White; Kate Wolitzky-Taylor; Jessica Santiago; Timothy J McDermott; Danielle C DeVille; Jennifer L Stewart; Martin Paulus; Charles T Taylor; Robin L Aupperle
Journal:  Behav Modif       Date:  2021-07-12

4.  Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies.

Authors:  Derek D Satre; Esti Iturralde; Murtuza Ghadiali; Kelly C Young-Wolff; Cynthia I Campbell; Amy S Leibowitz; Stacy A Sterling
Journal:  J Addict Med       Date:  2020-12       Impact factor: 4.647

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.